top of page
FORMULATION
DEVELOPMENT

SPAAR offers fully integrated capabilities for Generic product development in a variety of dosage forms comprising of Tablets, Capsules, Dry powders for suspension, Liquids, Injections, Oncology (solid orals and injections), Lyophilised product, Nanosuspension, Potent drugs and Eye drops. Our expertise in the areas of
product development and technology transfer helps us to partner with the clients from development to commercialization.

CAPABILITIES

SPAAR can work on very challenging projects on solids, liquids, injections and topicals which makes us a preferred partner.Our decades of experience in formulation development helps our partner to complete the project on time with quality and budget.Our QBD based formulation development helps our process easily
scalable and reproduce commercial lots successfully. 

PARTNERING

FULL SERVICE From initial Generic product development to commercialisation in a USFDA/EU approved facility SPAAR can work with partners on all aspects of formulation, analytical & process development upto manufacturing & approval. SPAAR offers clients to partner with us from any stage of Generic product development & are willing to have long term business relationship.

ADVANTAGE

Our product development quality is of top priority at a fair price when compared globally thus making us a preferred partner.

INJECTIONS

  • Lyophilized powder for solution

  • Suspension

  • Solution

  • Emulsion

TABLETS

  • Bilayer tablets, Delayed release tablets, Sustained release tablets & Extended release tablets

  • Immediate release tablets (highly insoluble molecules possessing bioequivalence challenges)

  • Highly sensitive molecules possessing physical and chemical incompatibilities

  • Hydrogel based drug delivery system

  • Osmotic drug delivery system

  • MUPS tablets (Pellets compressed into tablets)

  • Gastroretentive system (targeting stomach and intestine)

  • Delayed release ODT formulations

  • Orally disintegrating tablets

  • Taste masked ODT formulations

  • Chewable tablets

CAPSULES

  • Immediate and delayed release formulation comprising of simple and challenging molecules.

  • Pellets/powder filled into capsules

  • Mini tablets into capsules

  • Hydrogel based mini tablets into capsules

PELLETS

  • Delayed release pellets

  • Drug layered pellets

  • Pellets compressed as tablets

  • Pellets compressed as ODT formulation

SPECIALITY PRODUCTS

  • We provide technical and development support on customer specific speciality products and 505(b)2 products.

OTHER DOSAGE FORMS

  • Eye drops

  • Powder for suspension

  • Dry powder into sachets

  • Syrups

bottom of page